ライフサイエンスコーパス: acetylglucosaminyltransferase

1 synthesizing enzyme GCNT3 (core 2 beta-1,6 N-acetylglucosaminyltransferase).

2 l fringe is also a fucose-specific beta1,3-N-acetylglucosaminyltransferase.

3 mster ovary cells expressing core2 beta1,6-N-acetylglucosaminyltransferase.

4 ich is synthesized by I-branching beta1, 6-N-acetylglucosaminyltransferase.

5 , which are synthesized by core 2 beta-1,6-N-acetylglucosaminyltransferase.

6 network included alpha-dystroglycan and like-acetylglucosaminyltransferase.

7 olyzes UDP-GlcNAc, a sugar donor for Golgi N-acetylglucosaminyltransferases.

8 n, a proposed substrate of Fringe beta-1,3-N-acetylglucosaminyltransferases.

9 icient for the glycosyltransferase beta1,3-N-acetylglucosaminyltransferase 1 (beta3GnT1), a key enzym

10 Core 2 N-acetylglucosaminyltransferase 1 (C2GnT1) is a key enzyme

11 saminyltransferase (Mgat1), whose product, N-acetylglucosaminyltransferase 1 (GlcNAcT1) is necessary

12 atively, protein O-linked mannose beta-1,2-N-acetylglucosaminyltransferase 1 (POMGNT1) catalyzes the

13 Mutations in protein O-mannose B1,2-N-acetylglucosaminyltransferase 1 (POMGNT1), which is cruc

14 sease, mice deficient in O-mannose beta1,2-N-acetylglucosaminyltransferase 1 (POMGnT1).

15 ease, mice deficient in O-mannose beta31,2-N-acetylglucosaminyltransferase 1 (POMGnT1).

16 fukutin, protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase 1 and the fukutin-related

17 G was increased by co-expression of core 2 N-acetylglucosaminyltransferase 1 with Large.

18 s of an enzyme (protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 1) that modifies O-mannosy

19 ing protein O-mannosyltransferase 1, beta3-N-acetylglucosaminyltransferase 1, and like-acetylglucosam

20 sed by co-expression of protein:O-mannosyl N-acetylglucosaminyltransferase 1.

21 in the Golgi branching pathway, including N-acetylglucosaminyltransferases 1 and 2, which are requir

22 ted with the decreased expression of beta3-N-acetylglucosaminyltransferase-1 (beta3GnT1).

23 ands elaborated by LSST and core 2 beta1,6-N-acetylglucosaminyltransferase-1 (Core2GlcNAcT) have been

24 arge(myd) (myd) mice lack expression of like-acetylglucosaminyltransferase-1 (Large1) and exhibit sev

25 LARGE1 (Like-acetylglucosaminyltransferase-1) uniquely synthesizes ma

26 85 targets UDP-N-acetylglucosamine-peptide N-acetylglucosaminyltransferase 110 kDa subunit (OGT1) and

27 y the alternating iterative action of B1,3-N-acetylglucosaminyltransferase 2 (B3GNT2) and B1,4-galact

28 he alternating iterative action of beta1,3-N-acetylglucosaminyltransferase 2 (B3GNT2) and beta1,4-gal

29 Protein O-linked mannose beta-1,4-N-acetylglucosaminyltransferase 2 (POMGNT2) catalyzes the

30 (NExt) cell lines by overexpressing beta3-Nu-acetylglucosaminyltransferase 2 in MDCK, SIAT, and hCK c

31 Depressed beta1,6 N-acetylglucosaminyltransferase 2 in MM cells upregulated

32 Low beta1,6 N-acetylglucosaminyltransferase 2 levels correlated with p

33 me-associated genes and found that beta1,6 N-acetylglucosaminyltransferase 2 was downregulated and a

34 gh the loss of I-branching enzyme, beta1,6 N-acetylglucosaminyltransferase 2.

35 Core 2 N-acetylglucosaminyltransferase 2/M (C2GnT-M) synthesizes

36 Core2 beta1,6-N-acetylglucosaminyltransferase-2 (C2GnT-2) was markedly i

37 yltransferase (C1GalT1) and core 2 beta1,6-N-acetylglucosaminyltransferase-2 or mucus type (C2GnT-M),

38 , beta1,4-galactosyltransferase-I, beta1,3-N-acetylglucosaminyltransferase-2, hCGn6ST, and keratan su

39 In this study, we first show that beta1,3-N-acetylglucosaminyltransferase-3 (beta3GlcNAcT-3) is almo

40 in C2GnT-2 knock-out mice but not in core2 N-acetylglucosaminyltransferase-3 (C2GnT-3) nulls.

41 and LNCaP prostate cancer cells with beta3-N-acetylglucosaminyltransferase-6 (core3 synthase) require

42 EM domain nuclear lamina component by beta-N-acetylglucosaminyltransferase, a nutrient sensor that re

43 n in vitro glycosylation assay to evaluate N-acetylglucosaminyltransferase activity after bacterial e

44 residues that are known to be critical for N-acetylglucosaminyltransferase activity of yeast chitin s

45 proteins possess a fucose-specific beta1,3 N-acetylglucosaminyltransferase activity that initiates el

46 The mutant had normal levels of N-acetylglucosaminyltransferase activity, and the partiall

47 The former mutant lacks the Golgi N-acetylglucosaminyltransferase activity, whereas the latt

48 We conclude that beta-N-acetylglucosaminyltransferase, an essential enzyme, cont

49 poly-N-acetyllactosamines, while beta1, 3-N-acetylglucosaminyltransferase and beta4Gal-TI efficientl

50 nt cellular proteins catalyzed by O-linked N-acetylglucosaminyltransferase and O-linked N-acetylgluco

51 esence of the enzymes for addition (O-beta-N-acetylglucosaminyltransferase) and removal (O-beta-N-ace

52 The Fringe family of beta1,3-N-acetylglucosaminyltransferases are regulators of this pa

53 Golgi poly-LacNAc extension enzyme beta1,3-N-acetylglucosaminyltransferase (B3GNT).

54 beta1,3-N-acetylglucosaminyltransferases (B3GNTs) are Golgi-reside

55 B1,3-N-acetylglucosaminyltransferases (B3GNTs) are Golgi-reside

56 Fringe is a beta 3N-acetylglucosaminyltransferase (beta 3GlcNAcT) that trans

57 gene encoding the K. lactis Golgi membrane N-acetylglucosaminyltransferase by complementation of the

58 the alpha-1,3-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase C (MGAT4C) gene on 12q21.3

59 ized with the Golgi enzyme core 2 beta-1,6-N-acetylglucosaminyltransferase (C2 GlcNAcT).

60 lation of the expression of core-2 beta1,6-N-acetylglucosaminyltransferase (C2GnT) 1, a key enzyme re

61 ferase VII (Fuc-T VII) and core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT) are critical for b

62 sgenic mice overexpressing core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT) in T cells, and de

63 is synthesized only when core 2 beta-1, 6-N-acetylglucosaminyltransferase (C2GnT) is present, and th

64 BW5147 T cells lacking the core 2 beta-1,6-N-acetylglucosaminyltransferase (C2GnT) were resistant to

65 fucosyltransferase-VII, and core 2 beta1,6 N-acetylglucosaminyltransferase (C2GnT).

66 use they do not express the core 2 beta1 6-N-acetylglucosaminyltransferase (C2GnT).

67 s for galectin-1 created by core 2 beta1,6-N-acetylglucosaminyltransferase (C2GnT-I).

68 Core 2 beta-1,6-N-acetylglucosaminyltransferase, C2GnT, is a key enzyme in

69 we engineered mice lacking core 3 beta1,3-N-acetylglucosaminyltransferase (C3GnT), an enzyme predict

70 d Nod2 agonists upregulated core 3 beta1,3-N-acetylglucosaminyltransferase (C3GnT; an important enzym

71 cinoma AGS cells transfected with alpha1,4-N-acetylglucosaminyltransferase cDNA.

72 ions mediated by UDP-GlcNAc:GlcNAc-P-P-Dol N-acetylglucosaminyltransferase (chitobiosyl-P-P-lipid syn

73 irst demonstrate that I-branching beta1, 6-N-acetylglucosaminyltransferase cloned from human PA-1 emb

74 ne of the protein subunits of the alpha1-6-N acetylglucosaminyltransferase complex, which catalyses a

75 The four known mucin beta1,6-N-acetylglucosaminyltransferases contain nine conserved cy

76 d activity of glycosylating enzyme [beta]1,6 acetylglucosaminyltransferase (core 2 GlcNAc-T) is respo

77 The core 2 beta-1, 6-N-acetylglucosaminyltransferase (core 2 GnT) creates a bra

78 cloning of a HEV-expressed core1-beta 1,3-N-acetylglucosaminyltransferase (Core1-beta 3GlcNAcT) enab

79 f glycoproteins by leukocyte core2 beta1,6-N-acetylglucosaminyltransferase (Core2GlcNAcT-I).

80 ce sites SS#2 or SS#4 mostly via LARGE (like-acetylglucosaminyltransferase)-dependent glycans attache

81 roduced glycosyltransferases including key N-acetylglucosaminyltransferases (e.g., GnTI, GnTII, and G

82 The Golgi N-acetylglucosaminyltransferases encoded by Mgat1, Mgat2,

83 pemphigoid were characterized by marginal N-acetylglucosaminyltransferase expression and decreased N

84 e surface of the eye through inhibition of N-acetylglucosaminyltransferase expression in the Golgi.

85 strates equally, whereas the HS-initiating N-acetylglucosaminyltransferase EXTL3 is selective.

86 y non-conserved residue within the beta1,6-N-acetylglucosaminyltransferase family, Cys235, is also a

87 gation of O-fucose on Notch by the beta1,3-N-acetylglucosaminyltransferase Fringe modulates the abili

88 Upon expression of the beta3-N-acetylglucosaminyltransferase Fringe with Notch, we obse

89 lactosyltransferase or beta1-2- or beta1-6-N-acetylglucosaminyltransferase genes have been found in t

90 thesized in the presence of core 2 beta1,6-N-acetylglucosaminyltransferase, GlcAT-P, and HNK-1ST.

91 es glycolipids is catalyzed by the beta1,3 N-acetylglucosaminyltransferase GlcNAc(beta1,3)Gal(beta1,4

92 GlcNAc transfer is mediated by a distinct N-acetylglucosaminyltransferase (GlcNAc-T) activity.

93 f the glycosylating enzyme core 2 beta 1,6-N-acetylglucosaminyltransferase (GlcNAc-T) through protein

94 of the regulatory enzyme lactosylceramide N-acetylglucosaminyltransferase (GlcNAc-Tr) with age in vi

95 lucosamine (GlcNAc), which is generated by N-acetylglucosaminyltransferase (GnT)-IV, is a good substr

96 A paralog of GnT-Vb, N-acetylglucosaminyltransferase (GnT-V), is expressed in m

97 Our previous studies on a beta1,6-N-acetylglucosaminyltransferase, GnT-IX (GnT-Vb), a homolo

98 ts of the multisubunit enzyme complex, GPI-N-acetylglucosaminyltransferase (GPI-GnT), involved in the

99 s initiated by a multi-subunit enzyme, GPI-N-acetylglucosaminyltransferase (GPI-GnT).

100 iaA), and the undecaprenyl-phosphate alpha-N-acetylglucosaminyltransferase homolog (wecA) produced si

101 gnificantly lower levels of core 2 beta1,6 N-acetylglucosaminyltransferase I (C2GlcNAcT-I), but no di

102 Core 2 beta1,6-N-acetylglucosaminyltransferase I (C2GnT-I) plays a pivota

103 ose of transcripts encoding core 2 beta1,6-N-acetylglucosaminyltransferase I (Core2GlcNAcT-I).

104 The Mgat1 gene encodes N-acetylglucosaminyltransferase I (Glc-NAc-TI; EC 2.4.1.10

105 ylglucosamine:alpha-3-D-mannoside beta-1,2-N-acetylglucosaminyltransferase I (GlcNAc-TI, EC 2.4.1.101

106 lted in a marked and specific reduction in N-acetylglucosaminyltransferase I (GlcNAcT-I) activity and

107 ssion of erythropoietin (EPO) in a HEK293S N-acetylglucosaminyltransferase I (GnT I)(-/-) cell line r

108 N-acetylglucosaminyltransferase I (GNT-I) contributes to b

109 glycosylation caused by a mutation in the N-acetylglucosaminyltransferase I (GnT1) gene.

110 bryonic kidney 293 (HEK293S) cells lacking N-acetylglucosaminyltransferase I (GnTI(-)), and was recen

111 It was shown to lack N-acetylglucosaminyltransferase I (GnTI) activity, and con

112 e alpha-1,2-mannosidase and human beta-1,2-N-acetylglucosaminyltransferase I (GnTI) in the secretory

113 ften circumvent this problem by using B1,2-N-acetylglucosaminyltransferase I (MGAT1)-deficient mammal

114 n circumvent this problem by using beta1,2-N-acetylglucosaminyltransferase I (MGAT1)-deficient mammal

115 nt to the NH2-terminal retention signal of N-acetylglucosaminyltransferase I (NAGT I).

116 we identified a highly divergent T. brucei N-acetylglucosaminyltransferase I (TbGnTI) among a set of

117 dent UDP-GlcNAc:alpha3-D-mannoside beta1-2-N-acetylglucosaminyltransferase I activity (TbGnTI).

118 e O-glycan branching enzyme core 2 beta1,6-N-acetylglucosaminyltransferase I and its independent regu

119 and siRNA-mediated knockdown of the Golgi N-acetylglucosaminyltransferase I gene (MGAT1) induce part

120 nhibition of glycosylation in the Golgi by N-acetylglucosaminyltransferase I gene inactivation nor PN

121 s organism, no homologues of the canonical N-acetylglucosaminyltransferase I or II genes can be found

122 a-mannosidase I, Nicotiana tabacum beta1,2-N-acetylglucosaminyltransferase I, Arabidopsis Golgi alpha

123 the lowest levels, partial deficiencies in N-acetylglucosaminyltransferase I, II, and V (i.e. Mgat1,

124 lyltransferase, galactosyltransferase, and N-acetylglucosaminyltransferase I, was dramatically disrup

125 the protease was efficiently secreted from N-acetylglucosaminyltransferase I-deficient Lec1 Chinese h

126 te baculovirus, transduce HEK293S GnTI(-) (N-acetylglucosaminyltransferase I-negative) cells in suspe

127 expressed alpha-2,6-sialyltransferase and N-acetylglucosaminyltransferase-I (NAGT-I), both C-termina

128 electin ligands derived from core2 beta1,6-N-acetylglucosaminyltransferase-I null mice.

129 ly homologous to the I branching beta-1, 6-N-acetylglucosaminyltransferase (IGnT).

130 paucimannosidic N-glycans or elongated by N-acetylglucosaminyltransferase II (GNT-II) to produce com

131 erase family, encodes an equally divergent N-acetylglucosaminyltransferase II (TbGnTII) activity.

132 sect cell lines lacked adequate endogenous N-acetylglucosaminyltransferase II activity for biantennar

133 ng UDP-GlcNAc:alpha-6-d-mannoside beta-1,2-N-acetylglucosaminyltransferase II enzyme exhibit deficien

134 mammalian glycosyltransferases, including N-acetylglucosaminyltransferase II.

135 Mice lacking N-acetylglucosaminyltransferase III (GlcNAc-TIII) exhibit

136 N-acetylglucosaminyltransferase III (GlcNAc-TIII) is encod

137 N-Acetylglucosaminyltransferase III (GlcNAc-TIII), the pro

138 ene transfection of U373 MG cells with the N-acetylglucosaminyltransferase III (GnT-III).

139 gene expression of the responsible enzyme N-acetylglucosaminyltransferase III (GnT-III).

140 Downregulation of the bisecting N-acetylglucosaminyltransferase III (MGAT3) expression was

141 polylactosamine elongation by knockdown of N-acetylglucosaminyltransferase III or V had no effect on

142 N-Acetylglucosaminyltransferase-III (GnT-III) is a glycosy

143 Addition of O-GlcNAc by O-beta-N-acetylglucosaminyltransferase increased InsP(3)R-3 singl

144 chocystis sp. strain PCC6803, which encode N-acetylglucosaminyltransferases involved in peptidoglycan

145 on, suggesting developmental regulation of N-acetylglucosaminyltransferases IV and V and alpha6-fucos

146 ermore, the mRNA and protein expression of N-acetylglucosaminyltransferase IVa (GnT-IVa), which was r

147 f this capsular polysaccharide involves in N-acetylglucosaminyltransferase (KfiA) and d-glucuronyltra

148 The N-acetylglucosaminyltransferase known as GnT-Vb or -IX is

149 , which encodes an O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase known to modify epidermal

150 ing as a result of the silencing of the like-acetylglucosaminyltransferase (LARGE) gene in a cohort o

151 Like-acetylglucosaminyltransferase (LARGE) is a bifunctional

152 Like-acetylglucosaminyltransferase (LARGE) is a key molecule

153 of alpha-dystroglycan (alpha-DG) by the like-acetylglucosaminyltransferase (LARGE) is required for it

154 se-alpha1,3-glucuronic acid-beta1-]n by like-acetylglucosaminyltransferase (LARGE) is required for th

155 at this modification is mediated by the like-acetylglucosaminyltransferase (LARGE) protein.

156 (myd) mice as a result of a mutation in like-acetylglucosaminyltransferase (LARGE), a glycosyltransfe

157 synaptic strength, as does knockdown of like-acetylglucosaminyltransferase (LARGE)--a glycosyltransfe

158 2 branching enzyme, termed core 2 beta-1,6-N-acetylglucosaminyltransferase-leukocyte type (C2GnT-L),

159 Bovine core 2 beta1,6-N-acetylglucosaminyltransferase-M (bC2GnT-M) catalyzes the

160 sion of reporter N-linked glycoproteins in N-acetylglucosaminyltransferase MGAT1-null HEK293 cells to

161 h was enhanced by loss of Golgi-associated N-acetylglucosaminyltransferases MGAT1 or MGAT5.

162 (hexosamine pathway) and in turn to Golgi N-acetylglucosaminyltransferases Mgat1, -2, -4, and -5.

163 hat alpha-1,3-Mannosyl-Glycoprotein 2-beta-N-Acetylglucosaminyltransferase (MGAT1) served as the pivo

164 annosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (MGAT1), necessary for the

165 es (alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (MGAT1), transducing-like

166 nnosyl (alpha-1,3-)-glycoprotein beta-1,2- N-acetylglucosaminyltransferase (Mgat1), whose product, N-

167 le to interact with four different mannoside acetylglucosaminyltransferases (Mgat1, Mgat2, Mgat4B, an

168 n of beta-1,4-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase (MGAT3) (P < 0.001) and ot

169 annosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase (Mgat4) with UDP-GlcNAc.

170 annosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (Mgat5) in the Golgi membr

171 annosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (Mgat5).

172 Fringe O-fucose-beta1,3-N-acetylglucosaminyltransferases modulate Notch signaling

173 ue of the cellular core 2 protein beta-1,6-N-acetylglucosaminyltransferase-mucin type (C2GnT-M), whic

174 cation of a thermostable archaeal beta-1,4-N-acetylglucosaminyltransferase, named archaeal glycosylat

175 reased mRNA for nucleocytoplasmic O-linked N-acetylglucosaminyltransferase (ncOGT).

176 mutation in the gene encoding the alpha1-6-N-acetylglucosaminyltransferase necessary for the formatio

177 gosaccharides on the physiology of plants, N-ACETYLGLUCOSAMINYLTRANSFERASE (NodC) of Azorhizobium cau

178 ing the expression or activity of O-linked N-acetylglucosaminyltransferase, O-linked N-acetylglucosam

179 GnT1IP-L inhibits other N-glycan branching N-acetylglucosaminyltransferases of the medial Golgi.

180 O-Linked N-acetylglucosaminyltransferase (OGT) catalyzes the transf

181 r, the mRNA for nucleocytoplasmic O-linked N-acetylglucosaminyltransferase (OGT) increases 3.4-fold w

182 er did not have a soluble inhibitor of the N-acetylglucosaminyltransferase or a hexosaminidase that c

183 ligand-synthesizing enzymes core-2 beta1,6-N-acetylglucosaminyltransferase or fucosyltransferases IV/

184 n is evident in protein O-mannose beta-1,2-N-acetylglucosaminyltransferase (POMGnT1) knockout mouse,

185 an glycans, the protein O-mannose beta-1,2-N-acetylglucosaminyltransferase, POMGnT1.

186 ve identified an enzyme, polypeptide alpha-N-acetylglucosaminyltransferase (pp alpha-GlcNAc-T2), that

187 ZP3 and huZP3 affect the ability of core 2 N-acetylglucosaminyltransferase(s) to extend the core 1 se

188 up-regulated miRNAs, alpha-dystroglycan/like-acetylglucosaminyltransferase, spectrin, and myotrophin,

189 -N-acetylglucosaminyltransferase 1, and like-acetylglucosaminyltransferase that are required to synth

190 he B3GNT7 transcript, which encodes a B1-3-N-acetylglucosaminyltransferase that can participate in th

191 B3GNT7 transcript, which encodes a beta1-3-N-acetylglucosaminyltransferase that can participate in th

192 essed in cultured cells inhibit MGAT1, the N-acetylglucosaminyltransferase that initiates the synthes

193 We demonstrate that MGAT4A, an N-acetylglucosaminyltransferase that installs the beta-1,4

194 ucosyltransferase-1) and Fringe, a beta1,3-N-acetylglucosaminyltransferase that modifies O-fucose in

195 Fringe is a fucose-specific beta1,3-N-acetylglucosaminyltransferase that modifies O-fucose moi

196 ge proteins are O-fucose-specific beta-1,3 N-acetylglucosaminyltransferases that glycosylate the extr

197 Radical Fringe (LFNG, MFNG, and RFNG) are N-acetylglucosaminyltransferases that modify Notch recepto

198 Fringe proteins are beta3-N-acetylglucosaminyltransferases that modulate Notch activ

199 Fringe proteins are beta1,3-N-acetylglucosaminyltransferases that modulate signaling t

200 t in milk and the recently cloned beta-1,3-N-acetylglucosaminyltransferase, the formation of poly-N-a

201 ure of beta4Gal-TI and i-extension beta1,3-N-acetylglucosaminyltransferase, the major product was the

202 beta-1,6-N-Acetylglucosaminyltransferase V (EC 2.4.1.155) catalyzes

203 tivity and mRNA transcript levels encoding N-acetylglucosaminyltransferase V (GlcNAc-T V).

204 Changes in the levels of N-acetylglucosaminyltransferase V (GnT-V) can alter the fu

205 Beta1,6-acetylglucosaminyltransferase V (GnT-V) forms beta1,6 br

206 N-Acetylglucosaminyltransferase V (GnT-V) is an enzyme inv

207 The expression of N-acetylglucosaminyltransferase V (GnT-V) mRNA, which is r

208 mall interfering RNA-directed knockdown of N-acetylglucosaminyltransferase V (GnT-V), a glycosyltrans

209 man clinical samples, we demonstrated that N-acetylglucosaminyltransferase V (GnT-V)-mediated glycosy

210 eta(1,6)-linked GlcNAc, synthesized by the N-acetylglucosaminyltransferase V (GnT-V).

211 ycans caused by increased transcription of N-acetylglucosaminyltransferase V (GnT-V).

212 rides caused by increased transcription of N-acetylglucosaminyltransferase V (GnT-V).

213 including branched N-glycans generated by N-acetylglucosaminyltransferase V (Mgat5) activity, forms

214 anistically, ALK4 loss upregulates beta1,6 N-acetylglucosaminyltransferase V (MGAT5) and galectin-3,

215 N-Acetylglucosaminyltransferase V (MGAT5) mediates beta1,6

216 that beta1,6GlcNAc-branched complex-type (N-acetylglucosaminyltransferase V (Mgat5)) N-glycans on TC

217 e was recapitulated in mice lacking beta1,6N-acetylglucosaminyltransferase V (Mgat5), an enzyme respo

218 cancer cells, galectin-3 binding to beta1,6-acetylglucosaminyltransferase V (Mgat5)-modified N-glyca

219 tylglucosamine:alpha-6-D-mannoside beta1,6-N-acetylglucosaminyltransferase V (MGAT5)-modified N-glyca

220 c4 and Lec13 cells, which are defective in N-acetylglucosaminyltransferase V and GDP-fucose synthesis

221 aberrant N-glycosylation caused by altered N-acetylglucosaminyltransferase V(GnT-V, GnT-Va, and Mgat5

222 periments indicated that HG-CD147 contains N-acetylglucosaminyltransferase V-catalyzed, beta1,6-branc

223 A glycosyltransferase that branches O-Man, N-acetylglucosaminyltransferase Vb (GnT-Vb), is highly exp

224 ther Fringe, an O-fucose specific beta 1,3-N-acetylglucosaminyltransferase, was capable of modifying

225 over, beta4Gal-TIV, together with beta-1,3-N-acetylglucosaminyltransferase, was capable of synthesizi

226 identified one glycosyltransferase, core 2 N-acetylglucosaminyltransferase, which is down-regulated i

227 C2) is a protein O-linked mannose beta 1,4-N-acetylglucosaminyltransferase whose product could be ext

228 re we report this enzyme is not a beta-1,3-N-acetylglucosaminyltransferase with catalytic activity to